National Toxicology Program (NTP); Center for the Evaluation of Risks to Human Reproduction (CERHR); Availability of the Draft NTP Briefs on Genistein and Soy Formula; Request for Public Comments, 65537-65538 [E6-18796]
Download as PDF
<![CDATA[
Federal Register / Vol. 71, No. 216 / Wednesday, November 8, 2006 / Notices
cprice-sewell on PRODPC62 with NOTICES
reducing the yield of the active vaccine
component. Immediately available for
licensing is a strain that encodes a
mutated pertussis toxin, which does not
have to be chemically detoxified.
Application: Production of Bordatella
pertussis toxin for acellular vaccine use.
Inventors: Tod Merkel, Jerry Keith,
and Xiaoming Yang (NIDCR).
Patent Status: U.S. Patent No.
7,101,558 issued 05 Sep 2006 (HHS
Reference No. E–159–1999/0-US–03).
Licensing Status: Available for nonexclusive licensing.
Licensing Contact: Susan Ano, Ph.D.;
301/435–5515; anos@mail.nih.gov.
HSV–2 Diagnostic
Description of Technology: The
present invention relates to novel
diagnostic methods for Herpes Simplex
Virus Type 2 (HSV–2). HSV–2 infects
approximately one fifth of adults in the
United States and is the most common
cause of genital ulceration. The
invention relates to the detection of
HSV–2 based on a transforming nucleic
acid sequence and its protein product.
This DNA sequence harbors the
potential to induce the tumorigenic
transformation of normal cells in in
vitro and in vivo assays and thus will be
useful as a means of prognostic
evaluation in predicting the
development of genital or cervical
cancer. Current HSV–2 diagnostic tests
relying on tedious viral culture and/or
immunoassays that do not have the
sensitivity and the specificity essential
for diagnosis. Using PCR, the current
invention will provide a superior
method for viral detection and
subtyping.
Application: HSV–2 diagnostic.
Inventors: Joseph A. DiPaolo (NCI–)
Publication: JA DiPaolo et al.
Relationship of stable integration of
herpes simplex virus-2 Bg/II N
subfragment Xho2 to malignant
transformation of human
papillomavirus-immortalized cervical
keratinocytes. Int J Cancer 1998 Jun
10;76(6):865–871.
Patent Status: U.S. Patent 6,617,103
issued 09 Sep 2003 (HHS Reference No.
E–091–1999/0-US–03); CA Application
2,259,657 filed 30 Jun 1997 (HHS
Reference No. E–091–1999/0-CA–04).
Licensing Status: Available for nonexclusive or exclusive licensing.
Licensing Contact: Susan Ano, Ph.D.;
301/435–5515; anos@mail.nih.gov.
Collaborative Research Opportunity:
The NCI Division of Basic Science is
seeking statements of capability or
interest from parties interested in
collaborative research to further
develop, evaluate, or commercialize
HSV–2 Diagnostic. Please contact Betty
VerDate Aug<31>2005
15:11 Nov 07, 2006
Jkt 211001
Tong, Ph.D. at 301–594–4263 or
tongb@mail.nih.gov for more
information.
Dated: October 24, 2006.
Steven M. Ferguson,
Director, Division of Technology Development
and Transfer, Office of Technology Transfer,
National Institutes of Health.
[FR Doc. E6–18885 Filed 11–7–06; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Toxicology Program (NTP);
Center for the Evaluation of Risks to
Human Reproduction (CERHR);
Availability of the Draft NTP Briefs on
Genistein and Soy Formula; Request
for Public Comments
National Institute of
Environmental Health Sciences
(NIEHS); National Institutes of Health
(NIH).
ACTION: Request for comments.
AGENCY:
SUMMARY: CERHR invites the
submission of public comments on the
draft NTP Briefs on Genistein and Soy
Formula. The draft NTP Briefs are
available from the CERHR Web site
(https://cerhr.niehs.nih.gov see ‘‘CERHR
Reports & Monographs’’) or in hardcopy
from CERHR (see ADDRESSES below).
Public comments will be considered
during peer review and finalization of
the NTP Briefs.
DATES: Written comments on the draft
NTP Briefs on Genistein and Soy
Formula should be received by
December 8, 2006.
ADDRESSES: Public comments and any
other correspondence should be
addressed to Dr. Michael D. Shelby,
CERHR Director, NIEHS, P.O. Box
12233, MD EC–32, Research Triangle
Park, NC 27709 (mail), (919) 541–3455
(phone), (919) 316–4511 (fax), or
shelby@niehs.nih.gov (e-mail). Courier
address: CERHR, 79 T.W. Alexander
Drive, Building 4401, Room 103,
Research Triangle Park, NC 27709.
SUPPLEMENTARY INFORMATION:
Background
Genistein (CAS RN: 446–72–0) is a
phytoestrogen found in some legumes,
especially soybeans. Genistein is found
in many food products, especially soybased foods such as tofu, soy milk, and
soy infant formula, and in some overthe-counter dietary supplements. Soy
formula is fed to infants as a
supplement or replacement for human
milk or cow milk. On March 15–17,
2006, CERHR convened an expert panel
to conduct evaluations of the potential
PO 00000
Frm 00087
Fmt 4703
Sfmt 4703
65537
reproductive and developmental
toxicities of genistein and soy formula.
The expert panel reports were released
for public comment on May 5, 2006
(Federal Register Vol. 71, No. 94, pp.
28368, May 16, 2006). Following this
public comment period, CERHR staff
prepared draft NTP Briefs on Genistein
and Soy Formula that provides in plain
language:
• Background information on the
substance(s).
• Findings of the expert panel.
• Discussion of any relevant data
available after the expert panel meeting.
• NTP’s conclusions on the potential
for the substance to cause adverse
reproductive and/or developmental
effects in exposed humans.
Upon finalization, the NTP Briefs on
Genistein and Soy Formula will be
included in the CERHR Monographs on
Genistein and Soy Formula. The draft
NTP Briefs on Genistein and Soy
Formula and related background
materials, including the genistein expert
panel report, soy formula expert panel
report, and previously received public
comments, are available on the CERHR
Web site (https://cerhr.niehs.nih.gov see
Genistein and Soy Formula under
‘‘CERHR Reports & Monographs’’).
Request for Comments
The NTP invites written public
comments on the draft NTP Briefs on
Genistein and Soy Formula. Any
comments received will be posted on
the CERHR Web site and considered
during the peer reviews and finalization
of the NTP Brief on Genistein and the
NTP Brief on Soy Formula. Persons
submitting written comments are asked
to include their name and contact
information (affiliation, mailing address,
telephone and facsimile numbers, email, and sponsoring organization, if
any) and submit comments to Dr.
Shelby (see ADDRESSES above) for
receipt by December 8, 2006.
Background Information on CERHR
The NTP established CERHR in June
1998 [Federal Register, December 14,
1998 (Volume 63, Number 239, page
68782)]. CERHR is a publicly accessible
resource for information about adverse
reproductive and/or developmental
health effects associated with exposure
to environmental and/or occupational
exposures.
CERHR invites the nomination of
agents for review or scientists for its
expert registry. Information about
CERHR and the nomination process can
be obtained from its homepage (https://
cerhr.niehs.nih.gov) or by contacting Dr.
Michael Shelby, CERHR Director (see
ADDRESSES). CERHR selects chemicals
E:\FR\FM\08NON1.SGM
08NON1
65538
Federal Register / Vol. 71, No. 216 / Wednesday, November 8, 2006 / Notices
for evaluation based upon several
factors including production volume,
potential for human exposure from use
and occurrence in the environment,
extent of public concern, and extent of
data from reproductive and
developmental toxicity studies. Expert
panels conduct scientific evaluations of
agents selected by CERHR in public
forums. Following these evaluations,
CERHR prepares the NTP–CERHR
monograph on the agent evaluated. The
monograph is transmitted to appropriate
Federal and State agencies and made
available to the public.
Dated: October 31, 2006.
David A. Schwartz,
Director, National Institute of Environmental
Health Sciences and National Toxicology
Program.
[FR Doc. E6–18796 Filed 11–7–06; 8:45 am]
BILLING CODE 4140–01–P
Mitigation Grant Program. Grant
requirements, and grants management
procedures of the program are outlined
in 44 CFR Part 13.
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
Collection of Information
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Federal Emergency
Management Agency, DHS.
ACTION: Notice and request for
comments.
AGENCY:
SUMMARY: The Federal Emergency
Management Agency, as part of its
continuing effort to reduce paperwork
and respondent burden, invites the
general public and other Federal
agencies to take this opportunity to
comment on a proposed revision of a
currently approved information
collection. In accordance with the
Paperwork Reduction Act of 1995, this
notice seeks comments concerning the
Hazard Mitigation Grant Program
reporting requirements.
SUPPLEMENTARY INFORMATION: Section
404 of the Robert T. Stafford Disaster
Relief and Emergency Assistance Act,
44 U.S.C. 5170c, establishes the Hazard
Title: Hazard Mitigation Grant
Program Application and Reporting.
Type of Information Collection:
Revision of a currently approved
collection.
OMB Number: 1660–0076.
Form Numbers: None.
Abstract: Grantees administer the
Hazard Mitigation Grant Program,
which is a post-disaster program that
contributes funds toward the cost of
hazard mitigation activities in order to
reduce the risk of future damage
hardship, loss or suffering in any area
affected by a major disaster. FEMA uses
applications to provide financial
assistance in the form of grant awards
and, through grantee quarterly
reporting, monitors grantee project
activities and expenditure of funds.
Affected Public: State, local or tribal
government.
Estimated Total Annual Burden
Hours:
ANNUAL BURDEN HOURS
Number of
respondents
Frequency of
responses
Burden hours
per respondent
Annual
responses
Total annual
burden hours
(A)
Data collection activities/instruments
(B)
(C)
(D=A×B)
(E=C×D)
56
56
56
56
56
18
18
18
1
1
12
5
7.5
4
40
1008
1008
1008
56
56
12,096
5,040
7,560
224
2,240
Total Burden for HMGP ......................................
cprice-sewell on PRODPC62 with NOTICES
Project Narrative section 209.8(b) .............................
Benefit-Cost Determination ........................................
Environmental Review ...............................................
FEMA 345, HMGP Desk Reference ..........................
Annual Audit & Audit Trail Requirements ..................
56
56
..........................
3136
27,160
Estimated Cost: The State Hazard
Mitigation Office staff is usually
comprised of urban and regional
planners. Wage rates for urban and
regional planners were determined
using data from the U.S. Department of
Labor, Bureau of Labor Statistics (BLS).
Currently, BLS data indicate that the
median hourly earnings of urban and
regional planners for 2004 were $26.75
for an annualized cost of $726,530.
Comments: Written comments are
solicited to (a) evaluate whether the
proposed data collection is necessary for
the proper performance of the agency,
including whether the information shall
have practical utility; (b) evaluate the
accuracy of the agency’s estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) enhance the quality, utility, and
VerDate Aug<31>2005
15:11 Nov 07, 2006
Jkt 211001
clarity of the information to be
collected; and (d) minimize the burden
of the collection of information on those
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses. Comments must be
submitted on or before January 8, 2007.
Interested persons should
submit written comments to Chief,
Records Management and Privacy,
Information Resources Management
Branch, Information Technology
Services Division, Federal Emergency
Management Agency, 500 C Street, SW.,
Room 316, Washington, DC 20472.
ADDRESSES:
Policy Section, Mitigation Division,
(202) 646–3321 for additional
information. You may contact the
Records Management Branch for copies
of the proposed collection of
information at facsimile number (202)
646–3347 or e-mail address: FEMAInformation-Collections@dhs.gov.
Dated: November 2, 2006.
John A. Sharetts-Sullivan,
Chief, Records Management and Privacy
Information Resources Management Branch,
Information Technology Services Division,
Federal Emergency Management Agency,
Department of Homeland Security.
[FR Doc. E6–18834 Filed 11–7–06; 8:45 am]
BILLING CODE 9110–41–P
FOR FURTHER INFORMATION CONTACT:
Contact Cecelia Rosenberg, Chief, Grants
PO 00000
Frm 00088
Fmt 4703
Sfmt 4703
E:\FR\FM\08NON1.SGM
08NON1
]]>Agencies
[Federal Register Volume 71, Number 216 (Wednesday, November 8, 2006)]
[Notices]
[Pages 65537-65538]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-18796]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Toxicology Program (NTP); Center for the Evaluation of
Risks to Human Reproduction (CERHR); Availability of the Draft NTP
Briefs on Genistein and Soy Formula; Request for Public Comments
AGENCY: National Institute of Environmental Health Sciences (NIEHS);
National Institutes of Health (NIH).
ACTION: Request for comments.
-----------------------------------------------------------------------
SUMMARY: CERHR invites the submission of public comments on the draft
NTP Briefs on Genistein and Soy Formula. The draft NTP Briefs are
available from the CERHR Web site (https://cerhr.niehs.nih.gov see
``CERHR Reports & Monographs'') or in hardcopy from CERHR (see
ADDRESSES below). Public comments will be considered during peer review
and finalization of the NTP Briefs.
DATES: Written comments on the draft NTP Briefs on Genistein and Soy
Formula should be received by December 8, 2006.
ADDRESSES: Public comments and any other correspondence should be
addressed to Dr. Michael D. Shelby, CERHR Director, NIEHS, P.O. Box
12233, MD EC-32, Research Triangle Park, NC 27709 (mail), (919) 541-
3455 (phone), (919) 316-4511 (fax), or shelby@niehs.nih.gov (e-mail).
Courier address: CERHR, 79 T.W. Alexander Drive, Building 4401, Room
103, Research Triangle Park, NC 27709.
SUPPLEMENTARY INFORMATION:
Background
Genistein (CAS RN: 446-72-0) is a phytoestrogen found in some
legumes, especially soybeans. Genistein is found in many food products,
especially soy-based foods such as tofu, soy milk, and soy infant
formula, and in some over-the-counter dietary supplements. Soy formula
is fed to infants as a supplement or replacement for human milk or cow
milk. On March 15-17, 2006, CERHR convened an expert panel to conduct
evaluations of the potential reproductive and developmental toxicities
of genistein and soy formula. The expert panel reports were released
for public comment on May 5, 2006 (Federal Register Vol. 71, No. 94,
pp. 28368, May 16, 2006). Following this public comment period, CERHR
staff prepared draft NTP Briefs on Genistein and Soy Formula that
provides in plain language:
Background information on the substance(s).
Findings of the expert panel.
Discussion of any relevant data available after the expert
panel meeting.
NTP's conclusions on the potential for the substance to
cause adverse reproductive and/or developmental effects in exposed
humans.
Upon finalization, the NTP Briefs on Genistein and Soy Formula will
be included in the CERHR Monographs on Genistein and Soy Formula. The
draft NTP Briefs on Genistein and Soy Formula and related background
materials, including the genistein expert panel report, soy formula
expert panel report, and previously received public comments, are
available on the CERHR Web site (https://cerhr.niehs.nih.gov see
Genistein and Soy Formula under ``CERHR Reports & Monographs'').
Request for Comments
The NTP invites written public comments on the draft NTP Briefs on
Genistein and Soy Formula. Any comments received will be posted on the
CERHR Web site and considered during the peer reviews and finalization
of the NTP Brief on Genistein and the NTP Brief on Soy Formula. Persons
submitting written comments are asked to include their name and contact
information (affiliation, mailing address, telephone and facsimile
numbers, e-mail, and sponsoring organization, if any) and submit
comments to Dr. Shelby (see ADDRESSES above) for receipt by December 8,
2006.
Background Information on CERHR
The NTP established CERHR in June 1998 [Federal Register, December
14, 1998 (Volume 63, Number 239, page 68782)]. CERHR is a publicly
accessible resource for information about adverse reproductive and/or
developmental health effects associated with exposure to environmental
and/or occupational exposures.
CERHR invites the nomination of agents for review or scientists for
its expert registry. Information about CERHR and the nomination process
can be obtained from its homepage (https://cerhr.niehs.nih.gov) or by
contacting Dr. Michael Shelby, CERHR Director (see ADDRESSES). CERHR
selects chemicals
[[Page 65538]]
for evaluation based upon several factors including production volume,
potential for human exposure from use and occurrence in the
environment, extent of public concern, and extent of data from
reproductive and developmental toxicity studies. Expert panels conduct
scientific evaluations of agents selected by CERHR in public forums.
Following these evaluations, CERHR prepares the NTP-CERHR monograph on
the agent evaluated. The monograph is transmitted to appropriate
Federal and State agencies and made available to the public.
Dated: October 31, 2006.
David A. Schwartz,
Director, National Institute of Environmental Health Sciences and
National Toxicology Program.
[FR Doc. E6-18796 Filed 11-7-06; 8:45 am]
BILLING CODE 4140-01-P
